2018
DOI: 10.4049/jimmunol.1800141
|View full text |Cite
|
Sign up to set email alerts
|

Inhaled IL-10 Suppresses Lung Tumorigenesis via Abrogation of Inflammatory Macrophage–Th17 Cell Axis

Abstract: Intratracheal administration of a novel IL-10 formulation suppressed IL-17–driven, CD4+ T cell–dependent tumorigenesis in the LSL-K-rasG12D murine lung cancer model. Analysis of lung lymphocyte populations demonstrated that antitumor activity of IL-10 was associated with a 5-fold decline in Th17 cell prevalence and a concurrent suppression of inflammatory M1-like macrophage activity. Further phenotypic characterization revealed that macrophages and dendritic cells, but not Th17 cells, expressed IL-10RA on the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 29 publications
(19 citation statements)
references
References 39 publications
0
19
0
Order By: Relevance
“…25 The number of alveolar macrophages is associated with the degree of tumor progression, and M2 features of alveolar macrophages are increased during tumor progression. 25,26 Therefore, we examined whether changes in the absolute number or the phenotype of alveolar macrophages occur upon depletion of tumor-associated Tregs. Tregs ablation switched the activation status of BALF macrophages from an immunosuppressive M2-like major histocompatibility complex class II (MHC-II) low to a more inflammatory M1-like (MHC-II + ) state (Figure 7a).…”
Section: Tregs Ablation Resulted In Suppression Of M2 Type Of Macrophmentioning
confidence: 99%
“…25 The number of alveolar macrophages is associated with the degree of tumor progression, and M2 features of alveolar macrophages are increased during tumor progression. 25,26 Therefore, we examined whether changes in the absolute number or the phenotype of alveolar macrophages occur upon depletion of tumor-associated Tregs. Tregs ablation switched the activation status of BALF macrophages from an immunosuppressive M2-like major histocompatibility complex class II (MHC-II) low to a more inflammatory M1-like (MHC-II + ) state (Figure 7a).…”
Section: Tregs Ablation Resulted In Suppression Of M2 Type Of Macrophmentioning
confidence: 99%
“…Antibiotic treatment was ceased followed by fecal microbiota transplants (FMT) on 3 consecutive days. Fecal pellets were collected from each mouse prior to adenoviral-cre (Viral Vector Core Facility, University of Iowa) infection, and lung histological slides were done as described by Li et al [32]. Briefly, adenoviral infection was performed intranasally in anesthetized mouse with isoflurane at 2.5 × 10 7 PFUs per mouse in two 30-μL installations.…”
Section: Kras-driven Lung Adenocarcinomamentioning
confidence: 99%
“…Moreover, anti-PD-1 therapy redirected macrophages from an M2- to an M1-like phenotype [70]. Paradoxically, intratracheal administration of IL-10 suppressed lung tumorigenesis caused by activated K-ras G12D mutation, together with a dramatic M1 to M2 phenotypic change in IMs [71]. M2-polarized IMs suppressed Th17 functions, which is critical for lung tumorigenesis.…”
Section: Strategies To Use Intrapulmonary Macrophages As a Weapon mentioning
confidence: 99%